Cargando…
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
Autores principales: | Haberland, Annekathrin, Müller, Johannes, Wenzel, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994436/ https://www.ncbi.nlm.nih.gov/pubmed/30880373 http://dx.doi.org/10.1007/s10557-019-06874-0 |
Ejemplares similares
-
Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018) -
Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy
por: Wenzel, Katrin, et al.
Publicado: (2017) -
Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
por: Haberland, Annekathrin, et al.
Publicado: (2018) -
Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?
por: Haberland, Annekathrin, et al.
Publicado: (2013) -
Lack of efficacy of mono‐mode of action therapeutics in COVID‐19 therapy ‐ How the lack of predictive power of preclinical cell and animal studies leads developments astray
por: Haberland, Annekathrin, et al.
Publicado: (2021)